Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5268352 | 0.85 | — | — | |
| SCHEMBL6744848 | 0.85 | CYP2C19 (0.31) | — | |
| SCHEMBL6748966 | 0.80 | — | — | |
| SCHEMBL11237022 | 0.79 | TP53 (0.50) | TP53TDP1 | |
| SCHEMBL6744443 | 0.78 | — | — | |
| SCHEMBL10860471 | 0.75 | — | — | |
| SCHEMBL486485 | 0.72 | TSHR (0.31) | TDP1 | |
| SCHEMBL16504197 | 0.71 | — | — | |
| SCHEMBL10794992 | 0.71 | — | — | |
| SCHEMBL19348817 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024251966-A1 | CRYSTALLINE REDUCED NICOTINAMIDE MONONUCLEOTIDE (NMNH) AND PROCESS THEREOF | BOHAN & CO AS. (NO) | 2024-12-12 | — | — | WO | claimed |
| CN-115286899-B | Toughening-flame-retardant bisphenol type epoxy resin composite material and application thereof | 上海汉禾生物新材料科技有限公司 | 2023-06-16 | — | — | CN | claimed |
| CN-113004321-B | Method for desymmetrizing 3-substituted cyclobutanone, cyclobutene compound and application thereof | 复旦大学 | 2022-07-29 | — | — | CN | claimed |
| CN-113004321-A | Method for desymmetrizing 3-substituted cyclobutanone, cyclobutene compound and application thereof | 复旦大学 | 2021-06-22 | — | — | CN | claimed |
| US-20260138964-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4744667-A2 | EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF | The Queen's University Of Belfast (GB) | 2026-05-20 | — | — | EP | disclosed |
| EP-3890749-B1 | CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATMENT OF CANCER | SUMITOMO PHARMA AMERICA INC (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250270242-A1 | PHENETHYLAMINES AND CATHINONES PRECURSORS | TRANSCEND THERAPEUTICS, INC. (US) | 2025-08-28 | — | — | US | disclosed |
| EP-4605385-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | Transcend Therapeutics, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12371429-B2 | Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof | RECREO PHARMACEUTICALS LLC (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4573084-A1 | PHENETHYLAMINES AND CATHINONES PRECURSORS | Transcend Therapeutics, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20250197432-A1 | CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer | SUMITOMO PHARMA ONCOLOGY INC (US) | 2025-06-19 | — | — | US | disclosed |
| EP-0765160-B1 | DEXANABINOL DERIVATIVES AND THEIR USE AS NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS | UNIV RAMOT (IL) | 2003-04-16 | — | — | EP | disclosed |
| US-6096740-A | BLOCK N-METHYL-ASPARTATE | RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH AND INDUSTRIAL DEVELOPMENT LTD. (IL) | 2000-08-01 | — | — | US | disclosed |
| WO-1995020958-A1 | DEXANABINOL DERIVATIVES AND THEIR USE AS NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS | RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH AND INDUSTRIAL DEVELOPMENT LTD. (IL) | 1995-08-10 | — | — | WO | disclosed |
| US-4678609-A | Process for the preparation of corticosteroid-21-phosphoric acids and their salts and the corticosteroid-21-phosphoric acid triesters | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-07-07 | — | — | US | disclosed |
| US-4531004-A | Dimetronidazole phosphates | THE UPJOHN COMPANY (US) | 1985-07-23 | — | — | US | disclosed |
| US-4386079-A | PHOSPHORUS DERIVATIVES OF METRONIDAZOLE | THE UPJOHN COMPANY (US) | 1983-05-31 | — | — | US | disclosed |
| US-4212757-A | Peroxygen bleaching and compositions therefor | FMC CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |
| US-4065466-A | Integrated process for the preparation of 2-dialkoxyphosphinylimino-1,3-dithietane | AMERICAN CYANAMID COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12371429-B2 | Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof | CBR3, CBR1, CYP2B6 | TP53 3944/4885TDP1 3375/4885 |
| US-20250270242-A1 | PHENETHYLAMINES AND CATHINONES PRECURSORS | PNMT, COMT, SLC18A1 | TP53 4505/4885TDP1 790/4885 |
| US-20260138964-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | DMPK, CHKB, TTK | TP53 4425/4885TDP1 2525/4885 |
| US-20250197432-A1 | CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer | CDK9, CDK19, CDK7 | TP53 104/4885TDP1 506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.